RenovoRx Inc. (NASDAQ: RNXT)
$1.26
-0.0200 ( -1.56% ) 13.1K
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Market Data
Open
$1.26
Previous close
$1.28
Volume
13.1K
Market cap
$29.94M
Day range
$1.23 - $1.31
52 week range
$0.53 - $2.35
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 58 | Nov 13, 2023 |
8-k | 8K-related | 12 | Nov 06, 2023 |
4 | Insider transactions | 1 | Oct 04, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
8-k | 8K-related | 13 | Sep 11, 2023 |
8-k | 8K-related | 12 | Aug 25, 2023 |